GlassScriptPhysician profile
Waseem Albasha
NPI 1659720217
$1,749.86
in general payments reported to CMS, 2019-2025
22 companies · $850 in 2025
The $850 reported for 2025 was more than what 75% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $114 · 2022: $54.52 · 2023: $56.82 · 2024: $674 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,559 · Education: $22.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,558.98 |
| Education | $22.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $351.72 | 2020-2025 | Breztri, Airsupra, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.39 | 2024-2025 | Ofev |
| Pulmonx Corporation | $166.15 | 2023-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Insmed, INC. | $137.26 | 2024-2025 | Arikayce |
| Abiomed | $118.84 | 2025 | |
| Viatris Specialty LLC | $105.81 | 2025 | Yupelri |
| Baxter Healthcare | $95.86 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Mylan Specialty L.P. | $71.59 | 2024 | Yupelri |
| Genzyme Corporation | $62.23 | 2024-2025 | |
| Axsome Therapeutics, INC. | $57.61 | 2024-2025 | Sunosi |
| Olympus Corporation of The Americas | $55.46 | 2024 | Single Use Suction Valve (Sterile) |
| Olympus America INC. | $54.52 | 2022 | |
| Glaxosmithkline, LLC. | $47.12 | 2024-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Ani Pharmaceuticals, INC. | $30.11 | 2025 | Purified Cortrophin Gel |
| Inspire Medical Systems, INC. | $29.98 | 2025 | Inspire |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $29.55 | 2024 | Zemaira |
| Inogen, INC. | $27.46 | 2024 | |
| Merck Sharp & Dohme LLC | $26.60 | 2025 | Winrevair |
| Philips North America LLC | $25.63 | 2025 | Dreamwear |
| Zoll Respicardia, INC. | $23.52 | 2024 | Remede System |
| Regeneron Healthcare Solutions, INC. | $21.97 | 2024 | Dupixent |
| Avadel Cns Pharmaceuticals, LLC | $13.48 | 2024 | Lumryz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waseem Albasha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.